Mitochondria-Targeted Peptide SS-31 Treats High Blood Pressure Heart Damage
The mitochondria-targeted antioxidant peptide SS-31 ameliorated hypertensive cardiomyopathy in rats, reducing cardiac fibrosis, hypertrophy, and diastolic dysfunction — protecting the heart from high blood pressure damage.
Quick Facts
What This Study Found
The mitochondria-targeted antioxidant peptide SS-31 ameliorated hypertensive cardiomyopathy in rats, reducing cardiac fibrosis, hypertrophy, and diastolic dysfunction — protecting the heart from high blood pressure damage.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding The mitochondria-targeted antioxidant peptide SS-31 ameliorated hypertensive cardiomyopathy in rats, reducing cardiac fibrosis, hypertrophy, and diast
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2011.
- Original Title:
- Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.
- Published In:
- Journal of the American College of Cardiology, 58(1), 73-82 (2011)
- Authors:
- Dai, Dao-Fu, Chen, Tony, Szeto, Hazel, Nieves-Cintrón, Madeline, Kutyavin, Vassily, Santana, Luis F, Rabinovitch, Peter S
- Database ID:
- RPEP-01751
Evidence Hierarchy
Frequently Asked Questions
What was studied?
Mitochondria-Targeted Peptide SS-31 Treats High Blood Pressure Heart Damage
What was found?
The mitochondria-targeted antioxidant peptide SS-31 ameliorated hypertensive cardiomyopathy in rats, reducing cardiac fibrosis, hypertrophy, and diastolic dysfunction — protecting the heart from high blood pressure damage.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01751APA
Dai, Dao-Fu; Chen, Tony; Szeto, Hazel; Nieves-Cintrón, Madeline; Kutyavin, Vassily; Santana, Luis F; Rabinovitch, Peter S. (2011). Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.. Journal of the American College of Cardiology, 58(1), 73-82. https://doi.org/10.1016/j.jacc.2010.12.044
MLA
Dai, Dao-Fu, et al. "Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.." Journal of the American College of Cardiology, 2011. https://doi.org/10.1016/j.jacc.2010.12.044
RethinkPeptides
RethinkPeptides Research Database. "Mitochondrial targeted antioxidant Peptide ameliorates hyper..." RPEP-01751. Retrieved from https://rethinkpeptides.com/research/dai-2011-mitochondrial-targeted-antioxidant-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.